In agreement with the data of the present study, other reports have demonstrated that vinpocetine treatment ameliorates hepatic fibrosis in rats with an effective reduction in hepatic collagen deposition, hydroxyproline content, and α-SMA immunohistochemical expression (8, 44). The gene discussed is ACTA1; the disease is Hepatic fibrosis.